Bibliographic record

A phase 2 randomized trial of survodutide in MASH and fibrosis

Sanyal AJ, Bedossa P, Fraessdorf M, Neff GW, Lawitz E, Bugianesi E, Anstee QM, Hussain SA, Newsome PN, Ratziu V…. New England Journal of Medicine 2024

Document identifier: CEI-BR-098
Series: Bibliographic record
Version: 1.0
Published: 30 Jul 2026
Last reviewed: 30 Jul 2026
Certainty: Not rated

§1Bibliographic record

§1.1Record

Authors: Sanyal AJ, Bedossa P, Fraessdorf M, Neff GW, Lawitz E, Bugianesi E, Anstee QM, Hussain SA, Newsome PN, Ratziu V, Hosseini-Tabatabaei A, Schattenberg JM
Title: A phase 2 randomized trial of survodutide in MASH and fibrosis
Source: New England Journal of Medicine
Year: 2024
Volume, issue, pages: 391(4):311–319
Digital object identifier: 10.1056/NEJMoa2401755
PubMed identifier: 38847460
Record type: Journal article
Institute identifier: CEI-BR-098

§1.2Institute documents citing this record

Table 1. Documents in the Institute set that cite this record.

Document	Series
Monograph: Survodutide	Compound monograph
Synthesis: Survodutide in obesity and overweight in adults: effect on the anchor…	Evidence synthesis
Synthesis: Survodutide in obesity and overweight in adults: tolerability and…	Evidence synthesis
Synthesis: Survodutide in obesity and overweight in adults: durability of effect	Evidence synthesis
4 citing documents.

§1.3Subject tags

survodutide mash

Compound Evidence Institute · CEI-BR-098 · https://compoundevidence.com/bibliography/sanyal2024reta/ · retrieved 30 July 2026